ライフサイエンスコーパス: bacteriologically

1 The collected specimens were examined bacteriologically.

2 nic mutant in this trait (HBL-) was assessed bacteriologically and by slit lamp biomicroscopy, electr

3 stimate the prevalence of smear-positive and bacteriologically confirmed (either smear positive or cu

4 n the metabolic fingerprint of children with bacteriologically confirmed and unconfirmed TB compared

5 There were 77 bacteriologically confirmed cases and 41 Xpert MTB/RIF(R

6 Bacteriologically confirmed cases were more likely to ha

7 Bacteriologically confirmed cases were more likely to ha

8 Among bacteriologically confirmed children, Xpert Ultra on sto

9 trongly associated with an increased risk of bacteriologically confirmed disease at pre-entry screeni

10 positive for Mycobacterium tuberculosis and bacteriologically confirmed if M. tuberculosis was detec

11 etrospectively classified with tuberculosis, bacteriologically confirmed in 104 (43.0%).

12 A total of 48 of 402 (11.9%) bacteriologically confirmed incident recurrent TB cases

13 to diagnose LTBI among household contacts of bacteriologically confirmed index cases compared to HIV

14 ren with household exposure to an adult with bacteriologically confirmed MDR pulmonary tuberculosis.

15 We included patients with bacteriologically confirmed MDR-TB and known FQ and SLID

16 Of 447 children, 29 (6.5%) were bacteriologically confirmed on induced sputum and 72 (16

17 We considered children as bacteriologically confirmed on induced sputum if any tes

18 With "bacteriologically confirmed on induced sputum" as a refe

19 years or older with pulmonary tuberculosis (bacteriologically confirmed or clinically diagnosed).

20 sputum and saliva specimens from adults with bacteriologically confirmed pulmonary TB were also compa

21 fied 50 (0.2%) smear-positive and 101 (0.3%) bacteriologically confirmed pulmonary tuberculosis cases

22 r 100 000 people), whereas the prevalence of bacteriologically confirmed pulmonary tuberculosis has i

23 The estimated incidence of bacteriologically confirmed pulmonary tuberculosis in mi

24 Community-wide screening for bacteriologically confirmed pulmonary tuberculosis may r

25 ease according to the first case definition (bacteriologically confirmed pulmonary tuberculosis not a

26 0 (95% CI 103-233) per 100 000 people and of bacteriologically confirmed pulmonary tuberculosis was 4

27 (including clinically diagnosed cases), and bacteriologically confirmed pulmonary tuberculosis.

28 comprised household contacts of persons with bacteriologically confirmed rifampicin-resistant or mult

29 The incidence of febrile neutropenia and bacteriologically confirmed sepsis was unaffected by che

30 Through our efforts, bacteriologically confirmed TB notifications increased b

31 eatment; prevalence of undiagnosed/untreated bacteriologically confirmed TB on day 56; and undiagnose

32 36.1% and 79.7% (median, 50.4%) of prevalent bacteriologically confirmed TB was subclinical.

33 Six of the children with presumptive TB had bacteriologically confirmed TB, 52 children with unconfi

34 Chest Xray detected 89% (range, 73%-98%) of bacteriologically confirmed TB, highlighting the potenti

35 nd between prevalence of subclinical and all bacteriologically confirmed TB, patient diagnostic rate,

36 f 20789 pediatric TB cases, 5162 (24.8%) had bacteriologically confirmed TB.

37 city for, and were strongly associated with, bacteriologically confirmed TB.

38 esis that adjunctive rifampicin would reduce bacteriologically confirmed treatment failure or disease

39 The primary outcome was time to bacteriologically confirmed treatment failure or disease

40 216 participants with physician-suspected or bacteriologically confirmed tuberculosis from July 2017

41 Forty-five of 47 patients with bacteriologically confirmed tuberculosis had ESAT-6-spec

42 erum (n = 19) and urine (n = 3) samples from bacteriologically confirmed tuberculosis patients who we

43 s were screened, and the crude prevalence of bacteriologically confirmed tuberculosis was 92 (95% CI

44 The primary end point was bacteriologically confirmed tuberculosis within 30 month

45 clinical tuberculosis among individuals with bacteriologically confirmed tuberculosis, using various

46 The primary outcome was prevalence of bacteriologically confirmed tuberculosis.

47 cts were declared by 899 index patients with bacteriologically confirmed tuberculosis.

48 mmunodeficiency virus infection, and 14% had bacteriologically confirmed tuberculosis.

49 were adults with new or previously treated, bacteriologically confirmed, drug-sensitive pulmonary TB

50 ents were people aged 15 years or older with bacteriologically confirmed, drug-susceptible, pulmonary

51 firmed on induced sputum and 72 (16.1%) were bacteriologically confirmed.

52 B, metabolic profiling of sera distinguished bacteriologically-confirmed and clinical TB from other d

53 B) present subclinically, usually defined as bacteriologically-confirmed but negative on symptom scre

54 re recruited in The Gambia and classified as bacteriologically-confirmed TB, clinically diagnosed TB,

55 Pleural infection differs bacteriologically from pneumonia and requires different

56 Propionibacterium acnes, were identified in bacteriologically investigated samples from 53 of 54 pat

57 es above recommended CAD thresholds who were bacteriologically negative on routine baseline sputum we

58 Of the 74 (10.7%) participants who had bacteriologically positive (MTB+) results on Xpert testi

59 x patient with extrapulmonary TB compared to bacteriologically positive pulmonary TB (RR, 1.10 [95% C

60 IRR] = 1.136 [1.072, 1.204]; p <= 0.001) and bacteriologically positive TB (IRR = 1.141 [1.058, 1.229

61 were 2.21 (95% CI 1.92-2.54; 56 surveys) for bacteriologically positive TB and 2.51 (95% CI 2.07-3.04

62 a transtracheal swab, when both samples were bacteriologically positive the nasal swab identified the

63 factors of poor treatment outcomes included bacteriologically-positivity, low body mass index, no ph

64 original data for children hospitalized with bacteriologically-proven UTI who had undergone both MCU